SCHEDULE 13D/A
0001912273
XXXXXXXX
LIVE
7
Common Stock, par value $0.01 per share
01/14/2026
false
0000718937
852312305
STAAR SURGICAL CO
1911 WALKER AVE
MONROVIA
CA
91016
Christopher Min Fang Wang
852 37933457
Unit 3703, 37/F AIA Tower
183 Electric Road, North Point
Hong Kong
K3
00000
Andrew Freedman, Esq.
212-451-2300
Olshan Frome Wolosky LLP
1325 Avenue of the Americas
New York
NY
10019
Y
Yunqi Path Capital Master Fund
b
WC
N
E9
0.00
2575061.00
0.00
2575061.00
2575061.00
N
5.2
CO
0001912273
N
Yunqi Capital Limited
b
AF
N
K3
0.00
3257130.00
0.00
3257130.00
3257130.00
N
6.5
CO
IA
Y
Yunqi Capital Cayman Limited
b
AF
N
E9
0.00
3257130.00
0.00
3257130.00
3257130.00
N
6.5
CO
Y
Christopher Min Fang Wang
b
AF
N
Z4
0.00
3257130.00
0.00
3257130.00
3257130.00
N
6.5
IN
HC
Y
Yunqi China Special Investment A
b
WC
N
E9
0.00
682069.00
0.00
682069.00
682069.00
N
1.4
CO
Y
HS Group Master Fund II Ltd
b
AF
N
E9
0.00
682069.00
0.00
682069.00
682069.00
N
1.4
CO
Y
HS Group (Hong Kong) Limited
b
AF
N
K3
0.00
682069.00
0.00
682069.00
682069.00
N
1.4
CO
Y
HS Group Ltd
b
AF
N
E9
0.00
682069.00
0.00
682069.00
682069.00
N
1.4
CO
Common Stock, par value $0.01 per share
STAAR SURGICAL CO
1911 WALKER AVE
MONROVIA
CA
91016
This Amendment No. 7 amends the statement on Schedule 13D filed by Yunqi Capital Limited and other Reporting Persons on September 22, 2025, as amended on October 7, 2025, October 21, 2025, October 27, 2025, November 3, 2025, December 11, 2025 and January 8, 2026 (the "Schedule 13D").
On January 14, 2026, the Issuer entered into a letter agreement (the "Cooperation Agreement") with Broadwood Partners, L.P. pursuant to which the Issuer agreed, among other things, to appoint Christopher Min Fang Wang to its Board of Directors, effective as of the date of the Cooperation Agreement.
Yunqi Path Capital Master Fund
/s/ Christopher Min Fang Wang
Christopher Min Fang Wang / Director
01/16/2026
Yunqi Capital Limited
/s/ Christopher Min Fang Wang
Christopher Min Fang Wang / Director
01/16/2026
Yunqi Capital Cayman Limited
/s/ Christopher Min Fang Wang
Christopher Min Fang Wang / Director
01/16/2026
Christopher Min Fang Wang
/s/ Christopher Min Fang Wang
Christopher Min Fang Wang
01/16/2026
Yunqi China Special Investment A
/s/ Christopher Min Fang Wang
Christopher Min Fang Wang / Director
01/16/2026
HS Group Master Fund II Ltd
/s/ Michael Garrow
Michael Garrow / Director
01/16/2026
HS Group (Hong Kong) Limited
/s/ Michael Garrow
Michael Garrow / Director
01/16/2026
HS Group Ltd
/s/ Michael Garrow
Michael Garrow / Director
01/16/2026